Who backs Hemab Therapeutics Holdings?
12 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| Novo Holdings | Other |
| Sofinnova Partners | Venture capital |
| The Invus Group | PE / buyout |
| BioInnovation Institute | Other |
| Deep Track Capital | Venture capital |
| Maj Invest | PE / buyout |
| Rock Springs Capital | Hedge fund |
| Access Biotechnology | — |
| Avoro Capital | — |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Hemab Therapeutics Holdings investors
12 investors are on record for Hemab Therapeutics Holdings, including RA Capital Management, Novo Holdings, Sofinnova Partners and The Invus Group. The Series C in Oct 2025 drew 10 investors.
Free account
More of Hemab Therapeutics Holdings with a free account
- ·The complete investor list: 12 names
- ·Watch Hemab Therapeutics Holdings: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Hemab Therapeutics Holdings in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View